BR0015256A - Composições farmacêuticas contendo uma droga de antibiótico de fluoroquinolona e uma goma de xantano - Google Patents

Composições farmacêuticas contendo uma droga de antibiótico de fluoroquinolona e uma goma de xantano

Info

Publication number
BR0015256A
BR0015256A BR0015256-0A BR0015256A BR0015256A BR 0015256 A BR0015256 A BR 0015256A BR 0015256 A BR0015256 A BR 0015256A BR 0015256 A BR0015256 A BR 0015256A
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
xanthan gum
compositions containing
fluoroquinolone antibiotic
antibiotic drug
Prior art date
Application number
BR0015256-0A
Other languages
English (en)
Inventor
Bhagwati P Kabra
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of BR0015256A publication Critical patent/BR0015256A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

"COMPOSIçõES FARMACEUTICAS CONTENDO UMA DROGA DE ANTIBIóTICO DE FLUOROQUINOLONA E UMA GOMA DE XANTANO". São reveladas composições farmacêuticas contendo uma droga de antibiótico de fluoroquinolona, uma goma de xantano e um sal de cálcio solúvel em água em uma quantidade suficiente para tornar a droga de antibiótico de fluoroquinolona e a goma de xantano compatíveis.
BR0015256-0A 1999-11-01 2000-10-10 Composições farmacêuticas contendo uma droga de antibiótico de fluoroquinolona e uma goma de xantano BR0015256A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16269399P 1999-11-01 1999-11-01
PCT/US2000/028031 WO2001032181A2 (en) 1999-11-01 2000-10-10 Pharmaceutical compositions containing a fluoroquinolone antibiotic drug and xanthan gum

Publications (1)

Publication Number Publication Date
BR0015256A true BR0015256A (pt) 2002-06-18

Family

ID=22586735

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0015256-0A BR0015256A (pt) 1999-11-01 2000-10-10 Composições farmacêuticas contendo uma droga de antibiótico de fluoroquinolona e uma goma de xantano

Country Status (19)

Country Link
US (1) US6331540B1 (pt)
EP (1) EP1225898B1 (pt)
JP (1) JP2003513046A (pt)
KR (1) KR20020048967A (pt)
CN (1) CN1384745A (pt)
AR (1) AR026227A1 (pt)
AT (1) ATE243038T1 (pt)
AU (1) AU8008300A (pt)
BR (1) BR0015256A (pt)
CA (1) CA2386822A1 (pt)
DE (1) DE60003445T2 (pt)
DK (1) DK1225898T3 (pt)
ES (1) ES2199873T3 (pt)
HK (1) HK1045940A1 (pt)
MX (1) MXPA02004349A (pt)
PL (1) PL354928A1 (pt)
PT (1) PT1225898E (pt)
TR (1) TR200201174T2 (pt)
WO (1) WO2001032181A2 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050009922A1 (en) * 2001-01-27 2005-01-13 Carlson Paul E. Stable aqueous antimicrobial suspension
PT1567641E (pt) * 2001-08-24 2012-08-21 Uvic Industry Partnerships Inc Proaerolisina contendo sequência de activação de proteases e métodos de uso para o tratamento do cancro da próstata
ATE528003T1 (de) * 2002-07-31 2011-10-15 Senju Pharma Co Wässrige, flüssigkeitszubereitungen und lichtstabilisierte wässrige flüssigkeitszubereitungen
US8877168B1 (en) 2002-07-31 2014-11-04 Senju Pharmaceuticals Co., Ltd. Aqueous liquid preparations and light-stabilized aqueous liquid preparations
US8546423B2 (en) 2005-05-18 2013-10-01 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
EP1901749B1 (en) * 2005-05-18 2016-08-03 Raptor Pharmaceuticals Inc. Aerosolized fluoroquinolones and uses thereof
KR20090063252A (ko) * 2006-10-12 2009-06-17 교린 세이야꾸 가부시키 가이샤 향상된 안내 가티플록사신 이행성을 갖는 수성 액제
KR20110017844A (ko) * 2008-03-31 2011-02-22 교린 세이야꾸 가부시키 가이샤 가티플록사신을 함유하는 수성 액
JP5535900B2 (ja) * 2008-03-31 2014-07-02 杏林製薬株式会社 ガチフロキサシン含有水性液剤、その製造方法、および、該水性液剤の低温保存および凍結融解時の沈殿生成を抑制する方法
TWI495469B (zh) * 2008-06-09 2015-08-11 Alcon Res Ltd 含有氟喹諾酮抗生素藥物之經改良藥學組成物
JP2012505223A (ja) 2008-10-07 2012-03-01 エムペックス・ファーマシューティカルズ・インコーポレーテッド 薬物動態の改善のためのエアゾールフルオロキノロン配合物
EP2346509B1 (en) 2008-10-07 2020-05-13 Horizon Orphan LLC Inhalation of levofloxacin for reducing lung inflammation
RU2563809C2 (ru) 2009-09-04 2015-09-20 Мпекс Фармасьютикалс, Инк. Применение левофлоксацина в форме аэрозоля для лечения муковисцидоза
JP5306537B2 (ja) * 2010-02-24 2013-10-02 森永乳業株式会社 昆布抽出物を有効成分とする抗菌補助剤、抗菌組成物、及び飲食品
US9050357B2 (en) * 2010-03-08 2015-06-09 Cp Kelco U.S., Inc. Compositions and methods for producing consumables for patients with dysphagia
GR1008168B (el) 2013-03-14 2014-04-08 "Φαρματεν Α.Β.Ε.Ε.", Παρεντερικο σκευασμα αντιβακτηριακου παραγοντα φθοριοκινολονης και μεθοδος για την παρασκευη αυτου
JP6538322B2 (ja) * 2013-09-27 2019-07-03 三栄源エフ・エフ・アイ株式会社 液状とろみ剤
JP6602534B2 (ja) * 2013-09-27 2019-11-06 三栄源エフ・エフ・アイ株式会社 液状とろみ剤
JP6713728B2 (ja) * 2015-05-01 2020-06-24 三栄源エフ・エフ・アイ株式会社 液状増粘剤
EP3648740A1 (en) 2017-07-07 2020-05-13 EpicentRx, Inc. Compositions for parenteral administration of therapeutic agents
US12102632B2 (en) 2020-08-26 2024-10-01 Somerset Therapeutics, Llc Quinolone dispersions
US12016855B2 (en) 2020-08-26 2024-06-25 Somerset Therapeutics, Llc Prednisolone and moxifloxacin compositions and methods
US11510930B2 (en) 2020-08-26 2022-11-29 Somerset Therapeutics, Llc Gatifloxacin, prednisolone, and bromfenac compositions and methods
US11298315B2 (en) 2020-08-26 2022-04-12 Somerset Therapeutics, Llc. Triamcinolone and moxifloxacin compositions

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3944427A (en) 1970-04-06 1976-03-16 Itek Corporation Gelable and gelled compositions
US3700451A (en) 1970-04-06 1972-10-24 Itek Corp Gelable and gelled compositions
US3784712A (en) 1970-12-23 1974-01-08 Gen Foods Corp Gum gelling system xanthan-tara dessert gel
CA1070629A (en) 1975-11-10 1980-01-29 Allen I. Laskin Process for modifying biopolymers
US4135979A (en) 1976-08-24 1979-01-23 Merck & Co., Inc. Treatment of xanthan gum to improve clarity
US4136177A (en) 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
US4136173A (en) 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
US4136178A (en) 1977-01-31 1979-01-23 American Home Products Corp. Locust bean gum therapeutic compositions
GB8318403D0 (en) 1983-07-07 1983-08-10 Sutherland I W Gel-forming polysaccharides
FR2551087B1 (fr) 1983-08-30 1986-03-21 Rhone Poulenc Spec Chim Procede de traitement d'une solution de polysaccharide et son utilisation
DE3335593A1 (de) 1983-09-30 1985-04-11 Diamalt AG, 8000 München Gelier- und verdickungsmittel auf der basis von cassia-galactomannanen
US4717713A (en) 1983-10-31 1988-01-05 Research Corporation Controlled release liquid pharmaceutical
US4708861A (en) 1984-02-15 1987-11-24 The Liposome Company, Inc. Liposome-gel compositions
FR2588189B1 (fr) 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
US4647470A (en) 1985-11-27 1987-03-03 Merck & Co., Inc. Low-acetyl gellan gum blends
FR2618333B1 (fr) 1987-07-20 1990-07-13 Merck Sharp & Dohme Composition pharmaceutique et/ou cosmetique a usage topique contenant de la gomme rhamsam
US5192535A (en) 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
US4814160A (en) 1988-03-01 1989-03-21 Colgate-Palmolive Company Non-bleeding striped dentifrice
US5234957A (en) 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5446070A (en) 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
DE3843416A1 (de) 1988-12-23 1990-06-28 Wolff Walsrode Ag Xanthan mit verbesserter loeslichkeit und verfahren zur herstellung
CA2021414C (en) 1989-07-25 2004-09-28 Daniel H. Doherty Genetic control of acetylation and pyruvylation of xanthan gum
US5461081A (en) 1989-09-28 1995-10-24 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
FR2653021A1 (fr) 1989-10-17 1991-04-19 Merck Sharp & Dohme Composition ophtalmique aqueuse liquide a transition de phase liquide-gel.
ATE141502T1 (de) 1991-01-15 1996-09-15 Alcon Lab Inc Verwendung von karrageenan in topischen ophthalmologischen zusammensetzungen
US5212162A (en) 1991-03-27 1993-05-18 Alcon Laboratories, Inc. Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
DE69224071T2 (de) 1991-09-17 1998-05-07 Alcon Lab Inc Chinolan-antibiotika und polystyrolsulfonat enthaltende zusammensetzungen
US5192802A (en) 1991-09-25 1993-03-09 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
US5318780A (en) 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5473062A (en) 1992-10-29 1995-12-05 Takeda Chemical Industries, Ltd. Process for producing purified xanthan gum
JP3228315B2 (ja) 1993-04-23 2001-11-12 信越化学工業株式会社 キサンタンガムの汚染生菌数を減少させる方法
ES2068762B1 (es) * 1993-07-21 1995-12-01 Lipotec Sa Un nuevo preparado farmaceutico para mejorar la biodisponibilidad de drogas de dificil absorcion y procedimiento para su obtencion.
AU1567795A (en) 1994-01-14 1995-08-01 Lee Shahinian Jr. A method for sustained and extended corneal analgesia
US5422116A (en) 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system
ATE317690T1 (de) 1994-04-08 2006-03-15 Qlt Usa Inc Flüssige zusammensetzungen zur arzneistoffabgabe
US5523301A (en) 1994-08-05 1996-06-04 Merck & Co., Inc. Optic nerve health
EP0725628B1 (en) 1994-08-30 2001-11-07 Alcon Laboratories, Inc. Thermally-gelling drug delivery vehicles containing cellulose ethers
US5972326A (en) 1995-04-18 1999-10-26 Galin; Miles A. Controlled release of pharmaceuticals in the anterior chamber of the eye
FR2742336B1 (fr) 1995-12-19 1998-03-06 Chauvin Lab Sa Collyre destine notamment au traitement de l'oeil sec
SE9603480L (sv) 1996-09-23 1998-03-24 Johan Carlfors Beredningsform för svårlösliga läkemedel
FR2754712B1 (fr) 1996-10-17 1999-09-03 Merck Sharp Dohme Chibret Lab Compositions ophtalmiques
US5888493A (en) 1996-12-05 1999-03-30 Sawaya; Assad S. Ophthalmic aqueous gel formulation and related methods
WO1998053809A1 (en) 1997-05-30 1998-12-03 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
AU740874B2 (en) 1997-06-26 2001-11-15 Merck & Co., Inc. Method for optimizing retinal and optic nerve health
WO1999013861A1 (en) * 1997-09-12 1999-03-25 The Procter & Gamble Company Cleansing and conditioning article for skin or hair
EP1069913B1 (en) * 1998-04-07 2003-07-23 Alcon Laboratories, Inc. Gelling ophthalmic compositions containing xanthan gum
US6166012A (en) * 1999-07-30 2000-12-26 Allergan Sales, Inc. Antibiotic compositions and method for using same

Also Published As

Publication number Publication date
WO2001032181A3 (en) 2002-05-02
ES2199873T3 (es) 2004-03-01
DE60003445D1 (de) 2003-07-24
MXPA02004349A (es) 2003-09-22
PT1225898E (pt) 2003-10-31
WO2001032181A2 (en) 2001-05-10
EP1225898A2 (en) 2002-07-31
ATE243038T1 (de) 2003-07-15
AU8008300A (en) 2001-05-14
CA2386822A1 (en) 2001-05-10
JP2003513046A (ja) 2003-04-08
AR026227A1 (es) 2003-01-29
PL354928A1 (en) 2004-03-22
DK1225898T3 (da) 2003-09-15
US6331540B1 (en) 2001-12-18
DE60003445T2 (de) 2003-12-24
EP1225898B1 (en) 2003-06-18
HK1045940A1 (zh) 2002-12-20
KR20020048967A (ko) 2002-06-24
CN1384745A (zh) 2002-12-11
TR200201174T2 (tr) 2002-08-21

Similar Documents

Publication Publication Date Title
BR0015256A (pt) Composições farmacêuticas contendo uma droga de antibiótico de fluoroquinolona e uma goma de xantano
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
HRP20020880B1 (en) New pharmaceutical composition
YU57600A (sh) Derivarti biciklične hidroksaminske kiseline
EP1100522A4 (en) ADMINISTRATION OF ACTIVE AGENTS OVER THE LUNG
ATE495154T1 (de) Pharmazeutische zusammensetzungen, die ccr5- antagonisierende piperazinderivate enthalten
PL346764A1 (en) New oral formulation for 5-ht4
PT1121127E (pt) Composicoes farmaceuticas orais contendo buprenorfina
ZA200203077B (en) Ciclesonide contained pharmaceutical composition for application to mucosa.
DE69917796D1 (de) Decursin-enthaltende pharmazeutische zusammensetzungen
MXPA01011842A (es) Composiciones farmaceuticas para la administracion oral de floroglucinol y preparacion de las mismas.
ES2192789T3 (es) Derivados de hidrazono-benzazuleno, composiciones farmaceuticas y compuestos intermedios.
AU1258000A (en) Novel agarofuan derivatives, their preparation, pharmaceutical composition containing them and their use as medicine
DE60112578D1 (de) Pharmazeutische diclofenac-verbindung basierend auf vitamin e, papain und hyaluronidase
ATE208627T1 (de) Orale zusammensetzungen mit niedrigdosierten zytotoxischen proteinen
AU2001287489A1 (en) New agarofuran derivatives, their preparations, pharmaceutical compositions containing them and their uses as medicaments
FR2797446B1 (fr) Derives de phenanthroline-7-ones et leurs applications en therapeutique
YU5302A (sh) Derivati streptogramina, njihovo dobivanje i smeše koje ih sadrže
AU1584800A (en) Immuno-active, anti-cancer and pharmacologically active polysaccharide compoundsand pharmaceutical compositions containing the polysaccharide compounds
ATE252598T1 (de) Streptograminderivate, ihre herstellung und sie enthaltende zubereitungen
MY152490A (en) New oral formulation

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]